Table 2.

Efficacy of treatments

	AT group (n = 31)	CT group (n = 34)	P
Best overall response			0.763
Complete response	0	0
Partial response	14 (45.2%)	13 (38.2%)
Stable disease	15 (48.3%)	17 (50.0%)
Progressive disease	2 (6.5%)	4 (11.8%)
Objective response	14 (45.2%, 0.27–0.64)	13 (38.2%, 0.21–0.56)	0.571
Disease control	29 (93.5%, 0.84–1.03)	30 (88.2%, 0.77–1.00)	0.756

Data are n (%). Confirmed complete and partial responses were assessed by the investigator according to the Response Evaluation Criteria in Solid Tumors, version 1.1